During the past decade, Cardiology Associates of Schenectady conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Associates of Schenectady" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Spartan Bioscience Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Associates of Schenectady" are "Acute Coronary Syndrome" (1 trials), "Cardiovascular Disease" (1 trials), "Coronary Artery Disease" (1 trials), "Heart Failure" (1 trials) and "Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Cardiology Associates of Schenectady" in a lesser frequency.

Most popular intervention types in "Cardiology Associates of Schenectady" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Clopidogrel" (1 trials), "Methotrexate" (1 trials), "Placebo" (1 trials), "Placebo for tadalafil" (1 trials) and "Tadalafil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Associates of Schenectady" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology Associates of Schenectady". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cardiology Associates of Schenectady, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Associates of Schenectady, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".